Rangel-Muñoz, N.; Suarez-Arnedo, A.; Anguita, R.; Prats-Ejarque, G.; Osma, J.F.; Muñoz-Camargo, C.; Boix, E.; Cruz, J.C.; Salazar, V.A.
Magnetite Nanoparticles Functionalized with RNases against Intracellular Infection of Pseudomonas aeruginosa. Pharmaceutics 2020, 12, 631.
https://doi.org/10.3390/pharmaceutics12070631
AMA Style
Rangel-Muñoz N, Suarez-Arnedo A, Anguita R, Prats-Ejarque G, Osma JF, Muñoz-Camargo C, Boix E, Cruz JC, Salazar VA.
Magnetite Nanoparticles Functionalized with RNases against Intracellular Infection of Pseudomonas aeruginosa. Pharmaceutics. 2020; 12(7):631.
https://doi.org/10.3390/pharmaceutics12070631
Chicago/Turabian Style
Rangel-Muñoz, Nathaly, Alejandra Suarez-Arnedo, Raúl Anguita, Guillem Prats-Ejarque, Johann F. Osma, Carolina Muñoz-Camargo, Ester Boix, Juan C. Cruz, and Vivian A. Salazar.
2020. "Magnetite Nanoparticles Functionalized with RNases against Intracellular Infection of Pseudomonas aeruginosa" Pharmaceutics 12, no. 7: 631.
https://doi.org/10.3390/pharmaceutics12070631
APA Style
Rangel-Muñoz, N., Suarez-Arnedo, A., Anguita, R., Prats-Ejarque, G., Osma, J. F., Muñoz-Camargo, C., Boix, E., Cruz, J. C., & Salazar, V. A.
(2020). Magnetite Nanoparticles Functionalized with RNases against Intracellular Infection of Pseudomonas aeruginosa. Pharmaceutics, 12(7), 631.
https://doi.org/10.3390/pharmaceutics12070631